Fresenius SE & Co. KGaA
Provides critical biopharma, medtech, and hospital care for critically & chronically ill patients.
FRE | F
Overview
Corporate Details
- ISIN(s):
- CH1298665980 (+4 more)
- LEI:
- XDFJ0CYCOO1FXRFTQS51
- Country:
- Germany
- Address:
- Else-Kröner-Straße 1, 61352 Bad Homburg vor der Höhe
- Website:
- https://www.fresenius.com/
- Industry:
- Hospital activities
Description
Fresenius SE & Co. KGaA is a global healthcare company providing system-critical products and services for the care of critically and chronically ill patients. The Group comprises two primary operating companies, Fresenius Kabi and Fresenius Helios, and holds a strategic investment in Fresenius Medical Care. Fresenius Kabi specializes in a wide range of biopharmaceuticals, clinical nutrition, medical technologies, and intravenous generic drugs. Fresenius Helios is a leading private hospital and outpatient care operator in Germany and Spain. Through its #FutureFresenius strategic program, the company is focused on strengthening its core platforms—(Bio)Pharma, MedTech, and Care Provision—to drive innovation and long-term growth.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-17 13:47 | English | 78.6 KB | |||
| 2025-11-14 14:52 | English | 78.6 KB | |||
| 2025-11-06 09:19 | English | 4.7 KB | |||
| 2025-11-06 00:00 |
Q3 statement / Q3 financial report 2025
|
English | 685.1 KB | ||
| 2025-08-06 00:00 |
Half-yearly financial report 2025
|
English | 719.4 KB | ||
| 2025-07-04 08:03 | English | 77.9 KB | |||
| 2025-06-20 11:34 | German | 16.2 KB | |||
| 2025-05-07 00:00 |
Q1 statement / Q1 financial report 2025
|
English | 1.4 MB | ||
| 2025-04-24 00:00 |
Annual financial report 2024
|
English | 11.6 MB | ||
| 2025-04-17 00:00 |
Corporate Governance Declaration and Report 2024 of Fresenius SE & Co. KGaA
|
English | 618.6 KB | ||
| 2025-04-09 15:05 |
Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting …
|
English | 3.6 KB | ||
| 2025-04-02 14:40 |
Fresenius SE & Co. KGaA: Robert Moller, buy
|
English | 6.5 KB | ||
| 2025-04-01 16:16 | English | 16.1 KB | |||
| 2025-04-01 14:22 |
Fresenius SE & Co. KGaA: Sara Hennicken, buy
|
English | 6.5 KB | ||
| 2025-03-24 16:09 | English | 72.3 KB |
Automate Your Workflow. Get a real-time feed of all Fresenius SE & Co. KGaA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Fresenius SE & Co. KGaA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Fresenius SE & Co. KGaA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-08-04 | Moser, Dr. Michael | Board | Buy | None | 300,565.98 EUR |
| 2023-04-03 | Sen, Michael | Board | Buy | None | 586,989.25 EUR |
| 2023-04-03 | Hennicken, Sara | Board | Buy | None | 49,839.92 EUR |
| 2022-11-18 | De Meo, Dr. Francesco | Board | Buy | None | 50,415.29 EUR |
| 2022-08-29 | De Meo, Dr. Francesco | Board | Sell | None | 50,831.20 EUR |
| 2022-08-05 | Sturm, Stephan | Board | Buy | None | 119,831.44 EUR |
| 2022-08-05 | Sturm, Stephan | Board | Buy | None | 119,676.59 EUR |
| 2022-08-05 | Schmitt, Martin | Board | Buy | None | 5,150.00 EUR |
| 2022-06-10 | Sturm, Stephan | Board | Other | None | 54,089.64 EUR |
| 2022-06-10 | Kirsch, Wolfgang | Supervisory board | Other | None | 6,901.09 EUR |
Peer Companies
